ArticleInfection2026
Active screening for asymptomatic versus symptomatic tuberculosis in high-risk groups in a low-prevalence country: a retrospective study.
Article in Infection, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionAsymptomatic Tuberculosis (TB) represents up to 60% of cases in endemic countries, remains largely underdiagnosed and sustains transmission. Several European low-TB prevalence countries have implemented active screening in at-risk populations for identification of such cases. This study aims to describe clinical characteristics and possible risk factors of asymptomatic vs. symptomatic pulmonary TB cases in this setting.
methodsThis retrospective cohort study included pulmonary TB cases detected through active screening of at-risk populations at two Italian regional reference centers between 2015 and 2024. Asymptomatic and symptomatic cases were identified and compared.
resultsAmong 372 TB cases included, 56.5% belonged to the asymptomatic and 43.5% to the symptomatic group. Individuals from the first group required more often radiologic investigation with chest CT scan (145 [69%] vs. 78 [48.1%], p < 0.001). Cavitations were observed in both groups (75 [20%]); microbiologic confirmation by sputum culture, molecular methods or smear microscopy was more common in symptomatic patients (101 [75.9%] vs. 94 [63.1%], p = 0.02). Non-native individuals were more often symptomatic, younger, had history of previous TB and were more often screened due to exposure to congregate settings. Bivariate models showed that patient origin, previous TB disease history, chest CT scan and negative microbiology were associated with asymptomatic presentation, which was partly confirmed in multivariate models. DISCUSSION: Active screening in at-risk populations is essential to identify asymptomatic TB cases, which may display markers of infectiousness and therefore drive transmission. Epidemiologic risk profiling and advanced diagnostic strategies are necessary to improve early TB detection both in high and low prevalence countries.
Indexed as
Identifiers
42645682What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.